{"name":"Prospect Venture Partners","permalink":"prospect-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/prospect-venture-partners","homepage_url":"http://www.prospectventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"650-327-8800","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Jan 19 04:39:56 UTC 2009","updated_at":"Wed Jun 03 09:45:52 UTC 2009","overview":"<p>Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of capital under management. The firm is dedicated to investing in outstanding biopharmaceutical and medical device companies. Prospect targets commercially attractive biomedical enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technologies with the potential for significant investment returns.</p>\n\n<p>The firm invests in companies with a wide variety of development and financing requirements including new company incubations, first and second venture financing rounds, and later stage private and public companies with proven business models requiring expansion capital.</p>\n\n<p>Prospect Venture Partners seeks to ultimately invest $10-$20 million in each company as a lead investor or as a co-lead in an investor syndicate. First round investments generally range from $500,000 to $10 million. Prospect Venture Partners typically has representation on the board of each of its portfolio companies, and serves as an active partner. </p>","image":{"available_sizes":[[[150,81],"assets/images/resized/0003/4207/34207v1-max-150x150.png"],[[195,106],"assets/images/resized/0003/4207/34207v1-max-250x250.png"],[[195,106],"assets/images/resized/0003/4207/34207v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"435 Tasso Street","address2":"Suite 200","zip_code":"94301","city":"Palo Alto","state_code":"CA","country_code":"USA","latitude":37.44941,"longitude":-122.158948}],"relationships":[{"is_past":false,"title":"CFO","person":{"first_name":"Dave","last_name":"Markland","permalink":"dave-markland","image":{"available_sizes":[[[121,150],"assets/images/resized/0004/6459/46459v1-max-150x150.jpg"],[[151,187],"assets/images/resized/0004/6459/46459v1-max-250x250.jpg"],[[151,187],"assets/images/resized/0004/6459/46459v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Alex","last_name":"Barkas","permalink":"alex-barkas","image":{"available_sizes":[[[121,150],"assets/images/resized/0004/6461/46461v1-max-150x150.jpg"],[[151,187],"assets/images/resized/0004/6461/46461v1-max-250x250.jpg"],[[151,187],"assets/images/resized/0004/6461/46461v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Russell","last_name":"Hirsch","permalink":"russell-hirsch","image":{"available_sizes":[[[121,150],"assets/images/resized/0004/6460/46460v1-max-150x150.jpg"],[[151,187],"assets/images/resized/0004/6460/46460v1-max-250x250.jpg"],[[151,187],"assets/images/resized/0004/6460/46460v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=121646","source_description":"Biospace","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":2,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Capital Funding Report","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":19,"company":{"name":"Kythera Biopharmaceuticals","permalink":"kythera-biopharmaceuticals","image":{"available_sizes":[[[150,48],"assets/images/resized/0004/6451/46451v1-max-150x150.png"],[[250,80],"assets/images/resized/0004/6451/46451v1-max-250x250.png"],[[261,84],"assets/images/resized/0004/6451/46451v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Capital Funding Report","raised_amount":24550000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":1,"company":{"name":"NGM Biopharmaceuticals","permalink":"ngm-biopharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/9534/49534v1-max-150x150.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-250x250.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/visiogen-inc-series-d-40m/","source_description":"Visiogen, Inc.: Series D $40M","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":8,"company":{"name":"Visiogen","permalink":"visiogen","image":{"available_sizes":[[[89,72],"assets/images/resized/0005/0587/50587v1-max-150x150.jpg"],[[89,72],"assets/images/resized/0005/0587/50587v1-max-250x250.jpg"],[[89,72],"assets/images/resized/0005/0587/50587v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/complete-genomics-bags-45m-round-sequencing/2009-08-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Complete Genomics bags $45M round for sequencing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":24,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2006/09/06/alvine-pharma-raises-nearly-8m-from-prospect-sofinnova/","source_description":"Alvine Pharma raises nearly $8M from Prospect, Sofinnova","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":9,"funded_day":6,"company":{"name":"Alvine Pharmaceuticals","permalink":"alvine-pharmaceuticals","image":{"available_sizes":[[[136,51],"assets/images/resized/0005/9221/59221v1-max-150x150.jpg"],[[136,51],"assets/images/resized/0005/9221/59221v1-max-250x250.jpg"],[[136,51],"assets/images/resized/0005/9221/59221v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/06/12/roxro-pharma-raises-43m-for-pain-drugs/","source_description":"Roxro Pharma raises $43M for pain drugs","raised_amount":42700000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":12,"company":{"name":"Roxro Pharma","permalink":"roxro-pharma","image":{"available_sizes":[[[139,33],"assets/images/resized/0005/9481/59481v1-max-150x150.png"],[[139,33],"assets/images/resized/0005/9481/59481v1-max-250x250.png"],[[139,33],"assets/images/resized/0005/9481/59481v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2007/12/21/cogentus-pharma-raises-63m-for-blood-thinners/","source_description":"Cogentus Pharma raises $63M for blood thinners","raised_amount":62500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":21,"company":{"name":"Cogentus Pharmaceuticals","permalink":"cogentus-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2009/09/15/alvine-gobbles-215m-to-treat-gastrointestinal-disease/","source_description":"Alvine gobbles $21.5M to treat gastrointestinal disease","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"company":{"name":"Alvine Pharmaceuticals","permalink":"alvine-pharmaceuticals","image":{"available_sizes":[[[136,51],"assets/images/resized/0005/9221/59221v1-max-150x150.jpg"],[[136,51],"assets/images/resized/0005/9221/59221v1-max-250x250.jpg"],[[136,51],"assets/images/resized/0005/9221/59221v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.gloucesterpharma.com/press/releases/pr082509.html","source_description":"Gloucester Pharmaceuticals Completes $29 Million Financing","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":25,"company":{"name":"Gloucester Pharmaceuticals","permalink":"gloucester-pharmaceuticals","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/2317/62317v1-max-150x150.jpg"],[[236,115],"assets/images/resized/0006/2317/62317v1-max-250x250.jpg"],[[236,115],"assets/images/resized/0006/2317/62317v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2009/10/19/lux-biosciences-scores-50m-series-b-for-eye-cure/","source_description":"Lux Biosciences scores $50M Series B for eye cure","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":null,"company":{"name":"Lux Biosciences","permalink":"lux-biosciences","image":{"available_sizes":[[[123,82],"assets/images/resized/0006/3157/63157v1-max-150x150.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-250x250.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.satoripharma.com/news.html#Series_B_Press_Release","source_description":"Satori","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":8,"company":{"name":"Satori Pharmaceuticals","permalink":"satori-pharmaceuticals","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/5666/65666v3-max-150x150.png"],[[232,113],"assets/images/resized/0006/5666/65666v3-max-250x250.png"],[[232,113],"assets/images/resized/0006/5666/65666v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/01/11/dfine-takes-in-2-8m-to-heal-spinal-fractures/","source_description":"DFine takes in $2.8M to heal spinal fractures","raised_amount":2800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":11,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2010/01/neomend-closes-30m-funding-round.html","source_description":"Neomend Closes $30M Funding Round","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":27,"company":{"name":"Neomend","permalink":"neomend","image":{"available_sizes":[[[150,43],"assets/images/resized/0007/5202/75202v1-max-150x150.png"],[[225,65],"assets/images/resized/0007/5202/75202v1-max-250x250.png"],[[225,65],"assets/images/resized/0007/5202/75202v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ngm-lands-51m/2010-03-15?utm_medium=rss&utm_source=rss","source_description":"NGM lands $51M for preclinical diabetes work","raised_amount":51000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":15,"company":{"name":"NGM Biopharmaceuticals","permalink":"ngm-biopharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/9534/49534v1-max-150x150.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-250x250.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.kytherabiopharma.com/newsroom/article/entry1","source_description":"KYTHERA Raises $30 Million In Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":7,"funded_day":24,"company":{"name":"Kythera Biopharmaceuticals","permalink":"kythera-biopharmaceuticals","image":{"available_sizes":[[[150,48],"assets/images/resized/0004/6451/46451v1-max-150x150.png"],[[250,80],"assets/images/resized/0004/6451/46451v1-max-250x250.png"],[[261,84],"assets/images/resized/0004/6451/46451v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":11000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":7,"funded_day":6,"company":{"name":"Pathwork Diagnostics","permalink":"pathwork-diagnostics","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4707/84707v1-max-150x150.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-250x250.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/baxano-inc-series-c-30m/","source_description":"Baxano, Inc.: Series C $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":23,"company":{"name":"Baxano","permalink":"baxano","image":{"available_sizes":[[[150,40],"assets/images/resized/0012/2265/122265v1-max-150x150.jpg"],[[250,67],"assets/images/resized/0012/2265/122265v1-max-250x250.jpg"],[[273,74],"assets/images/resized/0012/2265/122265v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/07/15/dfine-raises-36-2m-to-repair-spine-fractures/","source_description":"DFine raises $36.2M to repair spine fractures","raised_amount":36200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":15,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.completegenomics.com/news-events/press-releases/Complete-Genomics-Inc-Announces-Completion-of-39-Million--Series-E-Financing-and-Addresses-Illumina-Patent-Infringement-Lawsuit-101026744.html","source_description":"Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing ","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":19,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":6400000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":29,"company":{"name":"Allux Medical","permalink":"allux-medical","image":null}}},{"funding_round":{"round_code":"d","source_url":"","source_description":"Cap Funding Report","raised_amount":41500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":9,"company":{"name":"nanosys","permalink":"nanosys","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/6895/96895v3-max-150x150.png"],[[250,53],"assets/images/resized/0009/6895/96895v3-max-250x250.png"],[[450,97],"assets/images/resized/0009/6895/96895v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/press-releases/ninepoint-medical-completes-33-million-series-financing","source_description":"NinePoint Medical Completes $33 Million Series A Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"NinePoint Medical","permalink":"ninepoint-medical","image":{"available_sizes":[[[150,83],"assets/images/resized/0010/6204/106204v1-max-150x150.jpg"],[[250,138],"assets/images/resized/0010/6204/106204v1-max-250x250.jpg"],[[285,158],"assets/images/resized/0010/6204/106204v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020101006e6a60008d&r=Rss&s=DJFVW","source_description":"Alta Partners Leads $30M Series C For Pathwork Diagnostics  ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":6,"company":{"name":"Pathwork Diagnostics","permalink":"pathwork-diagnostics","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4707/84707v1-max-150x150.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-250x250.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/01/surepoint-medical-receives-equity.html","source_description":"SurePoint Medical Receives Equity Investment from Prospect Partners","raised_amount":null,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":27,"company":{"name":"SurePoint Medical","permalink":"surepoint-medical","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/09/kythera-biopharmaceuticals-closed-37-4m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"KYTHERA Biopharmaceuticals Closed $37.4M Series D Financing","raised_amount":37400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":19,"company":{"name":"Kythera Biopharmaceuticals","permalink":"kythera-biopharmaceuticals","image":{"available_sizes":[[[150,48],"assets/images/resized/0004/6451/46451v1-max-150x150.png"],[[250,80],"assets/images/resized/0004/6451/46451v1-max-250x250.png"],[[261,84],"assets/images/resized/0004/6451/46451v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/azelon-pharmaceuticals-raises-4-5m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Azelon Pharmaceuticals Raises $4.5M Series A Financing","raised_amount":4500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":11,"company":{"name":"Azelon Pharmaceuticals","permalink":"azelon-pharmaceuticals","image":{"available_sizes":[[[150,94],"assets/images/resized/0015/7735/157735v1-max-150x150.png"],[[182,115],"assets/images/resized/0015/7735/157735v1-max-250x250.png"],[[182,115],"assets/images/resized/0015/7735/157735v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/10/topica-pharmaceuticals-raises-27m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"TOPICA Pharmaceuticals Raises $27M in Series B Funding","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":18,"company":{"name":"Topica Pharmaceuticals","permalink":"topica","image":{"available_sizes":[[[131,102],"assets/images/resized/0015/8649/158649v1-max-150x150.jpg"],[[131,102],"assets/images/resized/0015/8649/158649v1-max-250x250.jpg"],[[131,102],"assets/images/resized/0015/8649/158649v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/11/dfine-closes-25m-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"DFINE Closes $25M Equity Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":8,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/02/satori-pharmaceuticals-raises-15m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Satori Pharmaceuticals Raises $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":23,"company":{"name":"Satori Pharmaceuticals","permalink":"satori-pharmaceuticals","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/5666/65666v3-max-150x150.png"],[[232,113],"assets/images/resized/0006/5666/65666v3-max-250x250.png"],[[232,113],"assets/images/resized/0006/5666/65666v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/sentreheart-completes-26m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SentreHEART Completes $26M Series C Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":4,"company":{"name":"SentreHEART","permalink":"sentreheart","image":{"available_sizes":[[[150,61],"assets/images/resized/0019/3910/193910v1-max-150x150.png"],[[184,75],"assets/images/resized/0019/3910/193910v1-max-250x250.png"],[[184,75],"assets/images/resized/0019/3910/193910v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Health-Care Fund IV","funded_year":2010,"funded_month":8,"funded_day":18,"raised_amount":180000000,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100818e68i0002t&r=Rss&s=DJFVLS","source_description":"Prospect Venture Partners Secures $180M Toward Fourth Health-Care Fund"}],"video_embeds":[],"external_links":[]}